These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29437021)

  • 1. Homocysteine Levels in Autism Spectrum Disorder: A Clinical Update.
    Fuentes-Albero M; Cauli O
    Endocr Metab Immune Disord Drug Targets; 2018; 18(4):289-296. PubMed ID: 29437021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased homocysteine levels correlate with the communication deficit in children with autism spectrum disorder.
    Puig-Alcaraz C; Fuentes-Albero M; Calderón J; Garrote D; Cauli O
    Psychiatry Res; 2015 Oct; 229(3):1031-7. PubMed ID: 26070768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood homocysteine levels in children with autism spectrum disorder: An updated systematic review and meta-analysis.
    Guo BQ; Li HB; Ding SB
    Psychiatry Res; 2020 Sep; 291():113283. PubMed ID: 32763544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered urinary porphyrins and mercury exposure as biomarkers for autism severity in Egyptian children with autism spectrum disorder.
    Khaled EM; Meguid NA; Bjørklund G; Gouda A; Bahary MH; Hashish A; Sallam NM; Chirumbolo S; El-Bana MA
    Metab Brain Dis; 2016 Dec; 31(6):1419-1426. PubMed ID: 27406246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal transsulfuration metabolism and reduced antioxidant capacity in Chinese children with autism spectrum disorders.
    Han Y; Xi QQ; Dai W; Yang SH; Gao L; Su YY; Zhang X
    Int J Dev Neurosci; 2015 Nov; 46():27-32. PubMed ID: 26150135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum levels of macrophage migration inhibitory factor in autism spectrum disorders.
    Ning J; Xu L; Shen CQ; Zhang YY; Zhao Q
    Neurotoxicology; 2019 Mar; 71():1-5. PubMed ID: 30503813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited metabolic disorders in Turkish patients with autism spectrum disorders.
    Kiykim E; Zeybek CA; Zubarioglu T; Cansever S; Yalcinkaya C; Soyucen E; Aydin A
    Autism Res; 2016 Feb; 9(2):217-23. PubMed ID: 26055667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Homocysteine Levels Are Associated With the Metabolic Syndrome and Cardiovascular Events in Hypertensive Patients.
    Catena C; Colussi G; Nait F; Capobianco F; Sechi LA
    Am J Hypertens; 2015 Jul; 28(7):943-50. PubMed ID: 25498997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased homocysteine and lipoprotein(a) levels highlight systemic atherosclerotic burden in patients with a history of acute coronary syndromes.
    Cioni G; Marcucci R; Gori AM; Valente S; Giglioli C; Gensini GF; Abbate R; Boddi M
    J Vasc Surg; 2016 Jul; 64(1):163-70. PubMed ID: 27139787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel biomarkers of metabolic dysfunction is autism spectrum disorder: potential for biological diagnostic markers.
    Khemakhem AM; Frye RE; El-Ansary A; Al-Ayadhi L; Bacha AB
    Metab Brain Dis; 2017 Dec; 32(6):1983-1997. PubMed ID: 28831647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia among Omani autistic children: a case-control study.
    Ali A; Waly MI; Al-Farsi YM; Essa MM; Al-Sharbati MM; Deth RC
    Acta Biochim Pol; 2011; 58(4):547-51. PubMed ID: 22187679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results.
    Dittmann S; Seemüller F; Schwarz MJ; Kleindienst N; Stampfer R; Zach J; Born C; Bernhard B; Fast K; Grunze H; Engel RR; Severus E
    Bipolar Disord; 2007; 9(1-2):63-70. PubMed ID: 17391351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and Severity-Tracking Biomarkers for Autism Spectrum Disorder.
    Bjørklund G; Meguid NA; El-Ansary A; El-Bana MA; Dadar M; Aaseth J; Hemimi M; Osredkar J; Chirumbolo S
    J Mol Neurosci; 2018 Dec; 66(4):492-511. PubMed ID: 30357679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia: Impact on Neurodegenerative Diseases.
    Sharma M; Tiwari M; Tiwari RK
    Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):287-96. PubMed ID: 26036286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine: Its Possible Emerging Role in At-Risk Population Groups.
    Azzini E; Ruggeri S; Polito A
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyl-carnitine, C5DC, and C26 as potential biomarkers for diagnosis of autism spectrum disorder in children.
    Lv QQ; You C; Zou XB; Deng HZ
    Psychiatry Res; 2018 Sep; 267():277-280. PubMed ID: 29945069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced endogenous urinary total antioxidant power and its relation of plasma antioxidant activity of superoxide dismutase in individuals with autism spectrum disorder.
    Yui K; Tanuma N; Yamada H; Kawasaki Y
    Int J Dev Neurosci; 2017 Aug; 60():70-77. PubMed ID: 27554135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine as a Diagnostic and Etiopathogenic Factor in Children with Autism Spectrum Disorder.
    Józefczuk J; Kasprzycka W; Czarnecki R; Graczyk A; Józefczuk P; Magda K; Lampart U
    J Med Food; 2017 Aug; 20(8):744-749. PubMed ID: 28598237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron deficiency parameters in autism spectrum disorder: clinical correlates and associated factors.
    Gunes S; Ekinci O; Celik T
    Ital J Pediatr; 2017 Sep; 43(1):86. PubMed ID: 28934988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Amino Acid Dysregulation as a Potential Biomarker for Autism Spectrum Disorder in China.
    Zou M; Li D; Wang L; Li L; Xie S; Liu Y; Xia W; Sun C; Wu L
    Neurotox Res; 2020 Dec; 38(4):992-1000. PubMed ID: 32719995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.